24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Clinical genetics<br />

objectives <strong>of</strong> our study were to characterize the neuropsychological<br />

aspects <strong>of</strong> patients with MFDH, to correlate them with neuroimaging<br />

findings and to investigate the 22q11.2 deletion in these patients. Neuropsychological<br />

evaluation was performed using the Luria Nebraska<br />

Battery and WISC for children and WAIS for adults; the 22q11 .2 deletion<br />

was investigated by FISH . Heterogeneous results on neuropsychological<br />

evaluation involved difficulties cognitive domains such as<br />

picture arrangement, expressive language, comprehension, arithmetic,<br />

digit span and motors ability . These abnormalities are similar, in<br />

part, to those reported in deletion <strong>of</strong> 22q11 .2 region, which was not<br />

detected in all cases . In conclusion, we found a relationship between<br />

neuropsychological and radiological CNS alterations in MFDH . As the<br />

22q11 .2 region is recognized as critical for embryonary development<br />

<strong>of</strong> midline, in view <strong>of</strong> the clinical-genetic heterogeneity and the specified<br />

<strong>of</strong> the probe used, the involvement <strong>of</strong> 22q11.2 region in the etiology<br />

<strong>of</strong> MFDH needs to be further investigated .<br />

P01.289<br />

Associated malformations in patients with gastroschisis and<br />

omphalocele<br />

C. Stoll, Y. Alembik, B. Dott, M. Roth;<br />

Genetique medicale, Strasbourg, France.<br />

The etiology <strong>of</strong> gastroschisis and omphalocele (exomphalos) is unclear<br />

and their pathogenesis is controversial . However, the reported types<br />

and frequency <strong>of</strong> malformations associated with omphalocele and gastroschisis<br />

vary between studies . The purpose <strong>of</strong> this investigation was<br />

to assess, in a geographically defined population, the prevalences at<br />

birth <strong>of</strong> associated malformations in patients with omphalocele and gastroschisis<br />

which were ascertained between 1979 and 2003 in 334,262<br />

consecutive births . Of the 86 patients with omphalocele, 64 (74 .4%)<br />

had associated malformations including chromosomal abnormalities<br />

(25 cases,29 .0%); non chromosomal recognized syndromes including<br />

Beckwith-Wiedemann, Goltz, Marshall-Smith, Meckel-Gruber, Oto-palato-digital<br />

type II, CHARGE, and fetal valproate; sequences, including<br />

ectopia cordis, body stalk anomaly, exstrophy <strong>of</strong> bladder, exstrophy<br />

<strong>of</strong> cloaca, and OEIS; malformation complex including Pentalogy <strong>of</strong><br />

Cantrell, and patients with non syndromic multiple congenital anomalies<br />

(MCA) (26 cases, 30 .2%) . Malformations <strong>of</strong> the musculoskeletal<br />

system (23 .5%), the urogenital system (20 .4%), the cardiovascular<br />

system(15 .1%), and the central nervous system(9 .1%), were the most<br />

common other congenital anomalies occurring in patients with omphalocele<br />

and MCA . For gastroschisis, the total prevalence was 1 .79 per<br />

10,000. However, there was a significant increase over the study period<br />

in the total prevalence. The maternal age-specific prevalence was<br />

highest in the 15-19 year age group . Of the 60 patients with gastroschisis,<br />

10 (16 .6%) had associated malformations including one skeletal<br />

dysplasia, one amyoplasia congenita, and 7 non syndromic MCA . In<br />

conclusion the overall prevalences <strong>of</strong> malformations associated with<br />

omphalocele and gastroschisis are quite different and emphasizes the<br />

need for a thorough screening <strong>of</strong> cases for other malformations .<br />

P01.290<br />

Discordance <strong>of</strong> primary congenital glaucoma in monozygotic<br />

twins<br />

F. Suri 1,2 , S. Paylakhi 3 , S. Yazdani 4 , S. Zeinali 5 , M. Sajedifar 6 , S. Zargar 1 , E.<br />

Elahi 1,2 ;<br />

1 School <strong>of</strong> Biology, University College <strong>of</strong> Science, University <strong>of</strong> Tehran, Tehran,<br />

Islamic Republic <strong>of</strong> Iran, 2 National Institute <strong>of</strong> Genetic Engineering and Biotechnology,<br />

Tehran, Islamic Republic <strong>of</strong> Iran, 3 School <strong>of</strong> Biology, University College<br />

<strong>of</strong> Science, University <strong>of</strong> Tarbiat Modarres, Tehran, Islamic Republic <strong>of</strong> Iran,<br />

4 Ophthalmic Research Center, Shaheed Beheshti University <strong>of</strong> Medical Sciences,<br />

Tehran, Islamic Republic <strong>of</strong> Iran, 5 Biotechnology Department, Pastuer<br />

Institute <strong>of</strong> Iran, Tehran, Islamic Republic <strong>of</strong> Iran, 6 Kausar Biotechnology Company,<br />

Tehran, Islamic Republic <strong>of</strong> Iran.<br />

Glaucoma is a heterogeneous group <strong>of</strong> optic neuropathies characterized<br />

by degeneration <strong>of</strong> the optic nerve, usually associated with elevated<br />

intraocular pressure . It is the cause <strong>of</strong> 15% <strong>of</strong> blindness worldwide .<br />

Primary Congenital Glaucoma (PCG), one <strong>of</strong> the three major forms <strong>of</strong><br />

the disease, becomes apparent at birth or before the age <strong>of</strong> three and<br />

is a major cause <strong>of</strong> childhood blindness . Mutations in both alleles <strong>of</strong><br />

the cytochrome P4501B1 (CYP1B1) gene, which is the only gene thus<br />

far linked to PCG, result in the disease phenotype . It has been recently<br />

shown that mutations in this gene are cause <strong>of</strong> disease in approxi-<br />

mately 70% <strong>of</strong> Iranian PCG patients and that the common mutations in<br />

the population are G61E, R368H, R390H, and R469W .<br />

We report here the observation <strong>of</strong> highly variable expression <strong>of</strong> primary<br />

congenital glaucoma in two individuals who are identical twins .<br />

Both carried the G61E mutation in the homozygous sate . The identical<br />

twin status <strong>of</strong> the individuals was confirmed using several microsatellite<br />

markers .<br />

P01.291<br />

Cloning & Expression <strong>of</strong> <strong>Human</strong> rFVII in Insect Cells<br />

N. Masroori, M. Habibi Roudkenar PhD;<br />

Iranian Blood Transfusion Organization, Tehran, Islamic Republic <strong>of</strong> Iran.<br />

Hemophilia is the one <strong>of</strong> the most prevalent genetic disorders . It is<br />

inherited as sex-linked pattern . Obtaining factor from plasma or by recombinant<br />

technology, in high dose is one <strong>of</strong> the major challenges<br />

for treatment <strong>of</strong> Hemophilia . However 25% <strong>of</strong> these patients naturally<br />

raised antibody against factor VIII . Viral contamination and availability<br />

in very low dose is another challenge to obtain factor VIII from plasma .<br />

Administration <strong>of</strong> Recombinant factor VII for patients who raised antibody<br />

against FVIII can be one <strong>of</strong> the solution for mention problem .<br />

Isolation, cloning and expression <strong>of</strong> recombinant FVII by Gateway<br />

technology was the aim <strong>of</strong> this study . Factor VII gene was isolated from<br />

HepG 2 cell line and cloned to TOPO vector by TOPO cloning method .<br />

The construct was ligated to Baculovirus destination vector by LR recombination<br />

using getaway technology and the recombinant virus was<br />

transfected to, insect cell line, SF9 . Expression <strong>of</strong> recombinant FVII<br />

was detected by SDS-PAGE, ELISA and western blot analysis .<br />

P01.292<br />

A prenatally detected case <strong>of</strong> congenital hepatoblastoma<br />

H. Ergin 1 , B. Yildirim 2 , E. Dagdeviren 1 , B. Yagci 3 , F. Ozen 4 , N. Sen Turk 5 , S. E.<br />

Duzcan 5 ;<br />

1 Department <strong>of</strong> Pediatrics, Pamukkale University Faculty <strong>of</strong> Medicine, Denizli,<br />

Turkey, 2 Department <strong>of</strong> Obstetrics and Gynecology, Pamukkale University<br />

Faculty <strong>of</strong> Medicine, Denizli, Turkey, 3 Department <strong>of</strong> Radiology, Pamukkale<br />

University Faculty <strong>of</strong> Medicine, Denizli, Turkey, 4 Department <strong>of</strong> Pediatrics, Ege<br />

Hospital, Denizli, Turkey, 5 Department <strong>of</strong> Pathology, Pamukkale University<br />

Faculty <strong>of</strong> Medicine, Denizli, Turkey.<br />

Hepatoblastoma is a rare tumor <strong>of</strong> childhood . The incidence <strong>of</strong> hepatoblastoma<br />

in the first year <strong>of</strong> life is about one in a million. The mean<br />

time <strong>of</strong> its onset is 14 to 24 months . Forty-two congenital hepatoblastoma<br />

cases were reported so far . Among 42 congenital hepatoblastoma<br />

patients, seven cases have been detected in the prenatal period<br />

. Only one out <strong>of</strong> seven cases detected in the prenatal period has<br />

been diagnosed as hepatoblastoma . The etiology <strong>of</strong> hepatoblastoma<br />

is unknown . However, it has been shown to be associated with prematurity,<br />

low birth weight, hepatitis B, familial adenomatous polyposis,<br />

Beckwith-Wiedemann syndrome and hemihypertrophy . In this report,<br />

we report a rare case <strong>of</strong> hepatoblastoma detected before birth and<br />

confirmed by postmortem.<br />

P01.293<br />

Genotype-phenotype correlation in hereditary hemorrhagic<br />

telangiectasia in patients with ACVRL mutations: is c.1112dupG<br />

mutation a milder mutation?<br />

S. Dupuis-Girod 1 , S. Giraud 1 , E. Decullier 1 , B. Gilbert-Dussardier 2 , M. Carette 3 ,<br />

G. Plessis 4 , S. Riviere 5 , P. Magro 6 , G. Lesca 1 , P. Edery 1 , A. Calender 1 , H. Plauchu<br />

1 ;<br />

1 Hospices Civils de Lyon, LYON, France, 2 Hôpital Jean Bernard, POITIERS,<br />

France, 3 Assistance Publique - hôpitaux de Paris, PARIS, France, 4 Hôpital Côte<br />

de Nacre, CAEN, France, 5 Hôpital Saint Eloi, Montpellier, France, 6 Hôpital Bretonneau,<br />

TOURS, France.<br />

Introduction: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal<br />

dominant disorder characterized by recurrent epistaxis, cutaneous<br />

telangiectasia, and visceral arteriovenous malformations<br />

(AVMs) that affecting lungs (PAVM), gastrointestinal tract (DAVM), liver<br />

(HAVM), and brain (CAVM) and resulting from mutations in two major<br />

genes: ENG (HHT1) or ACVRL1 (HHT2) .<br />

Our objective was to determine the influence <strong>of</strong> c.1112dupG mutation<br />

on clinical phenotype in HHT2 patients .<br />

Methods: We retrospectively compared the frequency <strong>of</strong> clinical features<br />

<strong>of</strong> HHT between a subgroup <strong>of</strong> patients with mutation c .1112dupG<br />

(group A) and those with the other ACVRL1 mutations (group B), using<br />

0

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!